This task order is to conduct the testing of candidate antiviral therapies against VZV or hcmv in human skin xenograft mouse models and skin organ cultures in non-good laboratory practice (GLP)…
Active Awarded Last action
- Contract number
- 75N93026F00001
- Awardee
-
The Research Foundation For The State University Of New York UEI HYN3WD58HNN7 Part of The Research Foundation For The State University Of New York
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $480,856
Award facts
- Opportunity
-
- A21 Solicitation number
- Contract value 40% obligated
-
- $480,856.00 Current, with exercised options
- $1,213,570.00 Potential, with all options
- Completion date 29% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Syracuse, NY 13210, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a $1.21M firm fixed-price delivery order to The Research Foundation For The State University of New York (operating as Upstate Medical Center) on December 8, 2025, with completion targeted for December 7, 2028. This task order funds preclinical testing of candidate antiviral therapies against varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) using human skin xenograft mouse models and skin organ cultures under non-Good Laboratory Practice (GLP) conditions. The work will be performed in Syracuse, New York, and supports NIAID's Pre-Clinical Models of Infectious Diseases program. No small business set-aside designation applies to this award.
This delivery order is issued under a significantly larger $146.3M indefinite delivery contract between NIAID and The Research Foundation For The State University of New York focused on developing and employing animal and animal replacement models for infectious disease research. The parent IDV encompasses four task areas: small animal models, non-human primate models, alternative animal models, and specialized reagent generation. The foundation, which serves as the sponsored programs administrator for the State University of New York system, brings established expertise in translational research and preclinical modeling capabilities to support NIAID's mission of understanding, treating, and preventing infectious diseases through evaluation of potential medical countermeasures.
Description
This task order is to conduct the testing of candidate antiviral therapies against VZV or hcmv in human skin xenograft mouse models and skin organ cultures in non-good laboratory practice (GLP) conditions.
Quick answers
Who was awarded contract 75N93026F00001?
75N93026F00001 was awarded to The Research Foundation For The State University Of New York by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 8, 2025.
How much is contract 75N93026F00001 worth?
The government has obligated $480,856 on 75N93026F00001. Its potential value, with all options, is $1,213,570.
Is contract 75N93026F00001 an order under another contract?
Yes. 75N93026F00001 is a delivery order under 75N93024D00025, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93026F00001 competed?
The extent of competition for 75N93026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award